Kristin Ann Schmidt
Kristin Ann Schmidt is scheduled to speak at American Physical Therapy Association Annual on 5 February 2027.
Compiled from published conference agendas; not yet confirmed by Kristin. Is this you? Claim this profile.
About
Kristin Schmidt, PT, DPT is an Associate Director on the Endpoint Development and Strategy team at Ultragenyx, where she leads Clinical Outcome Assessment (COA) strategy across the clinical drug development lifecycle. A physical therapist and clinical researcher by training, she brings multidisciplinary clinical expertise to inform work across neurologic, pediatric, and rare disease populations. Dr. Schmidt specializes in the selection, development, and implementation of fit for purpose outcome measures in neurodevelopmental clinical trials. She partners cross functionally to design trials with clinically meaningful, patient focused, and globally feasible endpoints, supporting regulatory ready evidence that reflects how patients feel, function, and survive. Her work includes developing COA training frameworks and clinical evaluator curriculum focused on strengthening measurement rigor, standardization, and reliability to ensure data integrity across clinical trials. Grounded in clinica
Upcoming
American Physical Therapy Association Annual 4 February 2027 – 6 February 2027
- Physical Therapists Needed! from Movement Science to Drug Development: Expanding Our Professional Roles Speaker · 5 February 2027
Spoke alongside
People who have shared a session with Kristin at events on B2DB.
- Catherine Siener 1 shared session
- Margaret Ingels Allred Novartis Gene Therapies 1 shared session
- Trinh Tina Trung Duong Stanford University Medical Center 1 shared session